Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGracell Biotechn Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Gracell Biotechn Earnings Date And Information
Gracell Biotechn last posted its earnings results on Monday, March 11th, 2024. The company reported $-0.3 earnings per share for the quarter, missing analysts' consensus estimates of $-0.14 by $0.16. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Gracell Biotechn has generated $-45 earnings per share over the last year ($-44.85 diluted earnings per share) and currently has a price-to-earnings ratio of -1.58. Gracell Biotechn has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Gracell Biotechn Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2023 | Q3 2023 | N/A | -$4.05 | N/A | $0 | $0 |
| 08/14/2023 | Q2 2023 | -$0.37 | -$10.75 | -10.38 | $0 | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$11.20 | N/A | $125.00 K | $0 |
| 04/25/2023 | Q4 2022 | N/A | -$9.65 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$12.70 | N/A | N/A | $0 |
| 08/15/2022 | Q2 2022 | -$0.08 | -$10.70 | -10.62 | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$11.55 | N/A | N/A | $0 |
| 04/22/2022 | Q4 2021 | N/A | -$9.75 | N/A | $366.00 K | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$9.60 | N/A | $366.00 K | $366.00 K |
| 06/29/2021 | Q2 2021 | N/A | -$7.15 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$8.00 | N/A | N/A | $0 |
| 04/23/2021 | Q4 2020 | N/A | -$6.85 | N/A | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$3.85 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$11.55 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$8.05 | N/A | N/A | $0 |
| 12/31/2019 | Q4 2019 | N/A | -$10.80 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gracell Biotechn Earnings: FAQ's
The conference call for Gracell Biotechn's latest earnings report can be listened to online.
The conference call transcript for Gracell Biotechn's latest earnings report can be read online.
Gracell Biotechn (:GRCL) has a recorded net income of $-607,509,000.Gracell Biotechn has generated $-44.85 earnings per share over the last four quarters.
Gracell Biotechn (:GRCL) has a price-to-earnings ratio of -1.58 and price/earnings-to-growth ratio is -0.02.